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Copyright © 2008 AHC This study investigated the TNF-α-induced ICAM-1 and VCAM-1 expression on mouse lin-
gual lymphatic vessels. All podoplanin-positive lymphatic vessels expressed PECAM-1. In
the lamina propria mucosae of TNF-α-treated tongue, almost all initial lymphatics expressed
ICAM-1. There were initial lymphatics with the VCAM-1 expression and also the vessels
without the expression. In the tunica muscularis of TNF-α-treated tongue, collecting lymphat-
ic vessels expressed ICAM-1, but rarely expressed VCAM-1 whereas blood vessels simul-
taneously expressed ICAM-1 and VCAM-1. The ICAM-1-positive rate increased with TNF-α
to 75% from 10% on initial lymphatics, and to 40% from 0% on collecting lymphatic vessels
while it increased to 90% from 45% on blood vessels. The VCAM-1-positive rate increased
with TNF-α to 30% from 0% on initial lymphatics, and to 5% from 0% on collecting lymphatic
vessels while it increased to 75% from 5% on blood vessels. These findings suggest that
the lingual lymphatic endothelium has the ability to express ICAM-1, and VCAM-1 to a lesser
extent than the ICAM-1 induction with TNF-α, and that the ICAM-1 and VCAM-1 induction
predominantly occurs in the initial lymphatics compared with collecting lymphatic vessels.
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I. Introduction
The lymphatic vascular system maintains tissue fluid
homeostasis and mediates the afferent immune response.
Although the mechanisms that control the blood vascular
and immunocyte interaction system have been well studied,
those of the lymphatic vessels are poorly understood. In
blood vessels, the endothelium and immunocyte interaction
through leukocyte adhesion molecules contributes to leuko-
cyte extravasation at the inflammatory sites [20]. The
platelet-endothelial cell adhesion molecule-1 (PECAM-1)
which binds to PECAM-1 itself, heparan sulfate proteo-
glycans, and αvβ3 integrin, functions to promote leukocyte
transendothelial cell migrationv[2, 4–6, 14]. The intercellu-
lar adhesion molecule-1 (ICAM1) which binds to lympho-
cyte function-associated antigen-1 (LFA-1), and vascular
cell adhesion molecule-1 (VCAM-1) which binds to the
very late antigen 4 (α4β1), assist the migration and antigen-
specific response of lymphocytes [3, 12, 15]. Expression
of these molecules on blood endothelium increases with the
inflammatory cytokines [5]. It was previously reported that
the lymphatic endothelium of the human small intestine
usually expresses PECAM-1, but does not express endothe-
lial cell-selectin or ICAM-1 [16]. However in the inflamed
human small intestine, the lymphatic endothelium expresses
ICAM-1 and VCAM-1 [17]. It is possible that lymphatic
endothelium expresses leukocyte adhesion molecules under
immunologically activated conditions.
Recently, podoplanin has been reported as a new spe-
cific marker for a lymphatic endothelium. Normal lymphatic
vasculature formation requires podoplanin, and its defi-
ciency causes lymphedema [1, 9, 19]. This study examined
the expression of PECAM-1, ICAM-1, and VCAM-1 on the
lymphatic endothelium of the mouse tongue in the presence
of TNF-α.Iwasawa et al. 116
II. Materials and Methods
Immunohistochemistry
The tongue of eight-week-old closed colony ICR mice
(male, n=5; Charles River Japan Inc., Yokohama, Japan)
was obtained 24 hr after injections of a 0.01-ml volume of
saline containing 10 ng/ml of mouse TNF-α (DakoCytoma-
tion Co. Ltd., Copenhagen, Denmark) into the region of the
apex linguae, and of saline without TNF-α (sham) into the
region of the radix linguae. The collection of the tissue was
conducted after euthanasia by intraperitoneal injection with
sodium pentobarbital (10 ml/kg, Nembutal, Abbott Labora-
tories, North Chicago, IL). Mice were perfused through the
heart with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4). The protocol for animal use was reviewed and
approved by the animal experiment committee of Fukuoka
Dental College, Fukuoka, Japan. Immediately after trim-
ming off the injected regions, frozen 10 μm serial sections
were cut in a cryostat and fixed in 30% acetone in 10 mM
phosphate-buffered saline (PBS, pH 7.2) for 10 min at 4°C.
To identify the lymphatic vessels, this study used a hamster
monoclonal antibody specific to mouse podoplanin (Angio-
Bio Co., Del Mar, CA), and Alexa Fluor 488 (A488)-conju-
gated goat anti-hamster IgG (Invitrogen Com., Eugene, OR).
The expression of leukocyte adhesion molecules was exam-
ined by rat anti-mouse PECAM-1, ICAM-1, and VCAM-1
(R&D Systems Inc., Minneapolis, MN), and Alexa Fluor
568 (A568)-conjugated goat anti-rat IgG (Molecular
Probes). The sections were treated for 10 min at 25°C with
1% normal goat serum diluted with PBS, exposed by a first
antibody cocktail of 1 μg/ml of anti-podoplanin, and anti-
PECAM-1, ICAM-1, or VCAM-1, and treated with 100
ng/ml of A488- or A568-conjugated second antibodies
(Invitrogen) at 25°C for 1 hr. The sections were examined
by laser-scanning microscopy (Axiovert 135M, Carl Zeiss,
Jena, Germany) with a ×40 oil planapochromatic lens
(numerical aperture ×1.4). Confocal fluorescence images of
optical slices on the Z-axis were acquired at 0.5-μm intervals
within a depth of 4 to 9 μm below the cut surface. The digital
images were processed by a Zeiss LSM Image Browser
version 3.0 (Carl Zeiss).
Lymphatic and blood vessels usually express PECAM-
1 and podoplanin is a well-known lymphatic marker [10,
18]. This study investigated the ratio of lymphatic vessels
expressing ICAM-1, and VCAM-1 in mouse tongue with
TNF-α treatment. Adhesion molecule expression units were
expressed as percentages: number of vessels expressing
ICAM-1 or VCAM-1/total number of blood vessels ex-
pressing PECAM-1 or total number of lymphatic vessels
expressing PECAM-1 and podoplanin. Examination was
performed about ten visual fields in ×200. The statistical
significance of differences (p<0.001) was determined by the
unpaired two-tailed Student’s t test with STATVIEW 4.51
software (Abacus Concepts, Calabasas, CA).
III. Results
In the mouse apex linguae all lymphatic vessels
were immunostained with both anti-podoplanin and anti-
PECAM-1, and all blood vessels were immunostained with
only anti-PECAM-1. The glandula lingualis was immuno-
stained with anti-podoplanin but not with anti-PECAM-1
(Fig. 1). The inflammatory cell infiltration and vasodilation
were observed in the lamina propria mucosae and in the
lingual tunica muscularis, but not observed in the sham-
injected tissue (Fig. 2).
In the lamina propria mucosae there were initial lym-
phatics immunostained with anti-PECAM-1, and with anti-
ICAM-1 (Fig. 3). There were initial lymphatics with the
immunoreaction with anti-VCAM-1 and also the vessels
without the reaction (Figs. 3, 4). In the lingual tunica mus-
cularis collecting lymphatic vessels were immunostained
with anti-PECAM-1, and with anti-ICAM-1, but rarely with
anti-VCAM-1. It is also observed that there are blood ves-
sels simultaneously immunostained with anti-PECAM-1,
anti-ICAM-1, and anti-VCAM-1 (Fig. 5).
In the tissue without TNF-α, 45% of the blood vessels
and 10% of the initial lymphatics expressed ICAM-1, and
5% of the blood vessels but none of the lymphatic vessels
expressed VCAM-1. With TNF-α 90% of the blood vessels,
75% of the initial lymphatics, and 40% of the collecting
lymphatic vessels expressed ICAM-1 while 75% of the
blood vessels, 30% of the initial lymphatics, and 5% of the
collecting lymphatic vessels expressed VCAM-1 (Fig. 6).
IV. Discussion
Podoplanin, a 38-kDa membrane glycoprotein, is one
of the most highly expressed lymphatic-specific genes.
Podoplanin is expressed on the lymphatic endothelium with
the predominant localization to the luminal plasma mem-
brane of lymphatic vessels, but not on quiescent or prolifer-
ating blood endothelium. Podoplanin −/− mice have defects
in lymphatic vessel, but not blood vessel, pattern formation
[7, 13, 19], and was further characterized as podoplanin
because of its low level of expression in kidney podocytes
[1]. In the mouse tongue tissue, there was cross reaction
of anti-podoplanin to the glandula lingualis (Fig. 1), and
some somatic tissue cells including the epithelia of glands
may express the podoplanin gene. However in this study,
the antibody used to mouse podoplanin showed no reac-
tion to blood vessels expressing PECAM-1, ICAM-1, and
VCAM-1, with open-circled and regularly-outlined thick
walls which were easily distinguished from the podoplanin
and PECAM-1 positive lymphatic vessels (Figs. 1–4). These
results corresponded to studies of podoplanin expression
in the lymphatic vascular system [7–9, 11, 13]. Since all
lymphatic vessels expressed podoplanin and PECAM-1, all
blood vessels expressed PECAM-1, and glandula lingualis
was immunostained with anti-podoplanin but not with anti-
PECAM-1, it is thought that the double immunostaining
technique with anti-podoplanin and anti-PECAM-1 is usefulICAM-1 on Lymphatic Endothelium 117
Fig. 1. Expression of PECAM-1 and podoplanin on the mouse lingual lymphatic vessels. (a) H-E stained section of the mouse apex linguae.
(b) Immunostaining with anti-podoplanin of the section adjacent to a. Lymphatic vessels expressing podoplanin in the tunica muscularis are
visualized in green. The glandula lingualis is also immunostained with anti-podoplanin (arrow). (c) Merged image of immunostaining with
anti-podoplanin and anti-PECAM-1. Lymphatic vessels expressing podoplanin and PECAM-1 are visualized in yellow green while blood
vessels expressing only PECAM-1 are visualized in red. (d) High-magnification image of the region highlighted in a box in c. Lymphatic
vessels expressing podoplanin are visualized in green. The glandula lingualis is also immunostained with anti-podoplanin (arrow). (e) High-
magnification image of the region highlighted in a box in c. Lymphatic and blood vessels expressing PECAM-1 are visualized in red. The
expression of PECAM-1 is not observed in the glandula lingualis. (f) Merged image of d and e. Lymphatic vessels expressing both podoplanin
and PECAM-1 are visualized in yellow green (arrowheads) while blood vessels expressing only PECAM-1 are visualized in red. Bar=100 μm.
Fig. 2. Induction of inflammatory reaction
with TNF-α in the mouse tongue. H-E
stained section (original magnification ×40).
(a) Coronal section of the sham-injected
radix linguae. (b) Region highlighted in a
box in a. There is no inflammatory cell infil-
tration. (c) Sagittal section of the TNF-α-
injected apex linguae. Inflammatory cell
infiltration and vasodilation are observed in
a circle. (d) Region highlighted in a box in c.
Inflammatory cell infiltration and vasodila-
tion are observed in the lamina propria
mucosae and in the lingual tunica muscu-
laris (arrowheads). Bar=100 μm.Iwasawa et al. 118
Fig. 3. Expression of PECAM-1, ICAM-1, and VCAM-1 on the mouse initial lymphatics of the radix linguae. (a) Immunostaining with anti-
podoplanin and anti-PECAM-1 of the section adjacent to Figure 2b. (b) Immunostaining with anti-podoplanin and anti-ICAM-1 of the section
adjacent to a. (c) Immunostaining with anti-podoplanin and anti-VCAM-1 of the section adjacent to b. (d, e, f) High-magnification images of
regions highlighted in boxes in a, b, and c. Initial lymphatics expressing podoplanin, and PECAM-1 (d, arrowheads) or ICAM-1 (e, arrow-
heads) in the lamina propria mucosae are visualized in yellow green. Blood vessels are visualized in red with the immunoreaction to anti-
PECAM-1 (d, arrows) or anti-ICAM-1 (e, arrows), but not to anti-podoplanin. There are no initial lymphatics immunostained with anti-VCAM-
1. Bar=100 μm.
Fig. 4. Expression of VCAM-1 on the mouse
initial lymphatics of the radix linguae. (a) H-E
stained section. (b) Immunostaining with anti-
podoplanin of the section adjacent to a. Initial
lymphatics expressing podoplanin in the lam-
ina propria mucosae are visualized in green. (c)
Immunostaining with anti-VCAM-1 of the sec-
tion b. Vessels expressing VCAM-1 in the lam-
ina propria mucosae are visualized in red. (d)
Merged image of immunostaining with anti-
podoplanin and anti-VCAM-1. There are initial
lymphatics with the immunoreaction to anti-
VCAM-1 (arrows) and also the vessels without
the reaction (arrowheads). Bar=100 μm.ICAM-1 on Lymphatic Endothelium 119
in the discrimination of blood and lymphatic vessels with
regard to the tissue having cross reaction to anti-podoplanin
like salivary glands.
We have previously reported that the lymphatic endo-
thelium expresses multiple leukocyte adhesion molecules
including PECAM-1, ICAM-1, and VCAM-1, in inflamed
human small intestine [16, 17]. This study showed that the
inflammatory cell infiltration and vasodilation in the tongue
tissue injected with TNF-α, suggesting that the tissue treated
with TNF-α is useful as a inflammatory model (Fig. 2). In
the lamina propria mucosae of the TNF-α-treated tongue,
almost all initial lymphatics expressed ICAM-1. There
were initial lymphatics with the VCAM-1 expression and
also the vessels without the expression (Figs. 3, 4). In the
tunica muscularis of TNF-α-treated tongue, collecting lym-
phatic vessels expressed PECAM-1 and ICAM-1, but rarely
expressed VCAM-1 whereas blood vessels simultaneously
expressed PECAM-1, ICAM-1, and VCAM-1 (Fig. 5). The
ICAM-1-positive rate increased with TNF-α to 75% from
10% on initial lymphatics, and to 40% from 0% on collect-
ing lymphatic vessels while it increased to 90% from 45%
on blood vessels. The VCAM-1-positive rate increased with
TNF-α to 30% from 0% on initial lymphatics, and to 5%
from 0% on collecting lymphatic vessels while it increased
Fig. 5. Expression of PECAM-1, ICAM-1, and VCAM-1 on the mouse collecting lymphatic vessels of the lingual tunica muscularis. (a) Immu-
nostaining with anti-podoplanin and anti-PECAM-1 of the section adjacent to Figure 2d. (b) Immunostaining with anti-podoplanin and anti-
ICAM-1 of the section adjacent to a. (c) Immunostaining with anti-podoplanin and anti-VCAM-1 of the section adjacent to b. (d, e, f) High-
magnification images of regions highlighted in boxes in a, b, and c. The collecting lymphatic vessels expressing podoplanin, PECAM-1, and
ICAM-1, but not VCAM-1 are visualized in yellow green (arrowhead). It is also observed that the blood vessel simultaneously expressing
PECAM-1, ICAM-1, and VCAM-1 is visualized in red (arrow). Bar=100 μm.
Fig. 6. Ratio of lymphatic vessels expressing ICAM-1 and VCAM-
1 in mouse tongue with TNF-α. Without TNF-α 45% of blood ves-
sels (closed bar) and 10% of initial lymphatics (open bar) expressed
ICAM-1 while no collecting lymphatic vessels (grey bar) expressed
ICAM-1. With TNF-α 90% of blood vessels, 75% of initial lym-
phatics, and 40% of collecting lymphatic vessels expressed ICAM-
1. Without TNF-α 5% of blood vessels expressed VCAM-1 while
no lymphatic vessels expressed VCAM-1. With TNF-α 75% of
blood vessels, 30% of initial lymphatics, and 5% of collecting lym-
phatic vessels expressed VCAM-1. In all cases the ICAM-1 and
VCAM-1 expression was significantly higher in blood vessels than
lymphatic vessels. Data are expressed as mean±SEM.Iwasawa et al. 120
to 75% from 5% on blood vessels (Fig. 6). These findings
suggest that the lingual lymphatic endothelium has the abil-
ity to express ICAM-1, and VCAM-1 to a lesser extent than
the ICAM-1 induction with TNF-α, and that the ICAM-1
and VCAM-1 induction predominantly occurs in the initial
lymphatics compared with collecting lymphatic vessels. The
expression of adhesion molecules on the lymphatic endo-
thelium may aid immunocyte migration from tissue into the
lymphatic vessels.
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